Aurinia Pharmaceuticals (IKAP.F) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.18
-0.09
0
0.09

Details

Expected EPS
0.01388715
Actual EPS
0.09258100000000001
Surprise EPS
0.08
Surprise Percent
+566.67%

Description

Aurinia Pharmaceuticals (IKAP.F) has reported earnings of 0.09258100000000001 per share for Q4 2024.

0 Comments

Share your thoughts